Download PDF

Other users also viewed these articles

Antibiotic consumption, genetic risk and incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study Ziming Zheng; Yumei Huang; Jijuan Zhang; Jinchi Xie; An Pan; Yunfei Liao; Yu Zhang;
10.1016/j.aohep.2025.102136
Different measures of sodium intake and the risk of metabolic dysfunction-associated steatotic liver disease: Evidence from the UK Biobank Shiqi Zhu; Lihe Liu; Yiping Shen; Rui Li; Jiaxi Lin; Lu Liu; Xiaolin Liu; Hongpeng Sun; Jinzhou Zhu;
10.1016/j.aohep.2025.102145
Development and external validation of a machine-learning based model to predict pre-sarcopenia in MASLD population: Results from NHANES 2017¿2018 Siwei Yang; Jianan Yu; Qiyang Chen; Xuedong Sun; Yuefeng Hu; Tianhao Su; Jian Li; Long Jin;
10.1016/j.aohep.2024.101585